ILKO Pharmaceuticals

What ILKO Pharmaceuticals does

ILKO Pharmaceuticals (İLKO İlaç San. ve Tic. A.Ş.) is a privately held Turkish pharmaceutical manufacturer headquartered in Sancaktepe, Istanbul, with 501-1,000 employees and a subsidiary of the family-owned Selçuklu Holding. The company operates a vertically integrated structure spanning prescription pharmaceuticals (Rx), over-the-counter consumer health products (Wellcare brand), medical devices, high-potency non-sterile products (İLKOPOL subsidiary), and biotechnology drug development (İLKOGEN subsidiary). Its principal manufacturing complex sits on 250,000 m² in Konya's 3rd Organized Industrial Zone, operational since 2012, complemented by a dedicated Çerkezköy facility for high-potency products.

R&D is anchored by two centers: İLKO ARGEM (established 2009 at Hacettepe University Technology Development Zone, 2,600 m²) and İLKO ARGEM Biotechnology Center (established 2015 at Teknopark Istanbul, Turkey's first biotechnology R&D center), which develops recombinant DNA-based biosimilars, bio-betters, and nanobio-betters targeting oncology and immunology. The technology portfolio includes hydrophilic matrix, OROS, MUPS, multi-layer, orally disintegrating tablet (ODT), and topical drug delivery systems.

ILKO monetizes primarily through one-time sales of prescription drugs to physicians via a medical representative field force, distribution of OTC/Wellcare consumer health products through pharmacy retail networks, and emerging direct export channels in the Balkans (Albania, Kosovo, North Macedonia). The company holds comprehensive certifications (GMP, ISO 9001:2015, ISO 13485, ISO 14001, ISO 27001, ISO 50001, OHSAS 18001, Zero Waste) and supports its commercial offering with physician-facing digital platforms Medils, Kontrendike, and Fetal Risk. The Öncel family controls ownership, with Mustafa Öncel (founder) as Honorary President, İsmail Öncel as Chairman, and Hatice Öncel as General Manager.

Name

ILKO Pharmaceuticals

Legal name

İLKO İLAÇ SAN. ve TİC. A.Ş

Website

https://ilko.com.tr

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

501–1,000 employees

Short description

ILKO Pharmaceuticals is a privately held Turkish pharmaceutical manufacturer and subsidiary of Selçuklu Holding, producing prescription drugs, consumer health products (Wellcare), medical devices, and biotechnology drugs (İLKOGEN), serving physicians, pharmacies, and patients across Turkey and Balkan export markets.

Ownership category

akta.pro rank

Product category

Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

akta.pro secondary industries

Immunology & Autoimmune Specialty Pharmaceuticals (HLAIACAB), Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE)

Keywords

• Prescription pharmaceuticals
• Consumer health products
• Biotechnology drugs
• Medical devices
• Pharmaceutical manufacturing

Headquarters

HQ city

Sancaktepe

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Prescription Pharmaceutical Products: Branded generic and innovative pharmaceutical products sold through prescription channel. Includes products across therapeutic areas: cardiovascular, neurological, anti-infective, respiratory, musculoskeletal, and more.
2. Consumer Health / OTC Products: Wellcare brand consumer health products including supplements, vitamins, probiotics sold over-the-counter through pharmacy channels.
3. Medical Device Products: Medical device products including Sinomarin seawater nasal sprays, Constipass, Gaspass for respiratory and digestive health.
4. Biotechnology Products: Biosimilar and innovative biotechnological drugs developed through İLKOGEN for oncology and immunology applications.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Core offering

ILKO Pharmaceuticals manufactures prescription pharmaceutical products (Rx) covering cardiovascular, respiratory, neurological, infectious disease, and other therapeutic areas, produces consumer health products (Wellcare brand OTC supplements, probiotics, vitamins), medical devices (Sinomarin nasal sprays, Constipass, Gaspass), and develops biotechnology drugs (İLKOGEN biosimilars). The company operates a 250,000 m² manufacturing complex in Konya, plus two R&D centers — İLKO ARGEM at Hacettepe University Technology Development Zone and İLKO ARGEM Biotechnology Center at Teknopark Istanbul, Turkey's first biotechnology R&D center.

Product overview

İLKO İlaç is a Turkish pharmaceutical company organized as a multi-divisional structure with three core product lines (prescription/Rx drugs, consumer health/OTC products, and medical devices) supported by specialized subsidiaries and digital resources. İLKOPOL handles high-potency non-sterile production; İLKOGEN focuses on biotechnology R&D and biosimilar development; Wellcare serves consumer health needs. Digital platforms Medils, Kontrendike, and Fetal Risk provide medical literature and contraindication information. Two R&D centers (İLKO ARGEM and İLKO ARGEM Biotechnology Center) drive innovation in conventional and biotechnology-based pharmaceuticals.

Differentiator

Problem solved

Functional benefit

Brands

• Wellcare: Consumer health brand providing scientifically-backed health products with 'Art of Living with Health' approach
• İLKOPOL
• İLKOGEN
• Medils
• Kontrendike
• Fetal Risk

Products and services

• Prescription Pharmaceutical Products (Rx) Branded generic and innovative prescription pharmaceutical products covering therapeutic areas including cardiovascular, respiratory, neurology, gastroenterology, endocrinology, dermatology, and infectious diseases. Includes products such as Alecast (montelukast), Valcor (valsartan), Quelept (quetiapine), Regapen (pregabalin), and antibiotics. Sold via medical representative network to doctors and dispensed through pharmacies.
• Wellcare Consumer Health Products (OTC) Over-the-counter consumer health products under the Wellcare brand with 'Art of Living with Health' philosophy. Includes Provim probiotic line, collagen supplements, CoQ10, bromelain, vitamins, and minerals. Distributed through pharmacy networks directly to consumers for preventive health and nutritional supplementation.
• Medical Device Products Medical device products including Sinomarin seawater nasal sprays, Constipass (macrogol) for constipation, Gaspass (simethicone) for digestive health, and other medical devices manufactured under ISO 13485 quality standards.
• İLKOPOL High-Potency Non-Sterile Pharmaceutical Products High-potency non-sterile pharmaceutical products manufactured at a dedicated ISO-certified production facility in Çerkezköy. Quality-assured local production under the İLKOPOL brand.
• İLKOGEN Biotechnology Pharmaceutical Products Turkey's first biotechnology drug research, development, production and international marketing company. Develops biosimilar, bio-better, nano-bio-better, and next-generation biotechnological products using recombinant DNA technology. Focus on oncology and immunology to reduce Turkey's dependence on foreign biotechnological products.
• İLKO ARGEM Pharmaceutical R&D Services Pharmaceutical research and development services at İLKO ARGEM, located in Hacettepe University Technology Development Zone. Conducts analytical, formulation, patent, and clinical research focused on high-value products, specialized drugs, and biological drugs. Capabilities include conventional tablet/capsule, modified release systems, multi-layer tablets, ODT, and topical formulations.
• İLKO ARGEM Biotechnology Center R&D Services Biotechnology research and development services at İLKO ARGEM Biotechnology Center, located at Teknopark Istanbul. Uses recombinant DNA technology to develop biotechnological products for cancer and cancer-related diseases, with work on biosuperior, nanobiosuperior, biosimilar, and next-generation biotech products. Integrated cell-line-to-production infrastructure.

Quantifiable outcome

• Turkey's first biotechnology R&D center
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Twelve partnerships are on record, tiered growth, core and minor.

• Business Partners in Albania, Kosovo, and North MacedoniagrowthChannel Partner/ Reseller/ Distributor · 25 February 2026External Markets team conducted strategic visits to business partners in Balkan countries for 2026 and beyond planning. Discussions focused on strengthening portfolio positioning and identifying new product opportunities for regional growth.
• Selçuklu HoldingcoreStrategic or Co-development PartnerParent company of İLKO Pharmaceuticals. Selçuklu Holding encompasses İLKO İlaç operations. Onursal başkan (Honorary President) Mustafa Öncel's activities in pharmaceutical sector investments date back to 1960s magistral drug production.
• İLKOPOLcoreOthersSubsidiary brand for high potent non-sterile products manufacturing. Operates as a separate facility in Çerkezköy with ISO-certified quality systems for specialized pharmaceutical production.
• İLKOGENcoreOthersTurkey's first biotechnology drug R&D, production and international marketing company. Focuses on biosimilar development in oncology and immunology to reduce Turkey's dependence on foreign biotechnological products.
• WellcarecoreOthersConsumer health brand bringing scientific and differentiated approach to consumer health field. Focuses on preventive health with 'Art of Living with Health' philosophy.
• Mustafa Öncel FoundationcoreStrategic or Co-development PartnerFoundation under Selçuklu Holding conducting education and culture-arts activities. Provides scholarships, supports Mustafa Öncel Primary School, Kamer Öncel Vocational Technical Anatolian High School, and Mustafa Öncel Culture and Sports Complex.
• Tohum Otizm Vakfı (Autism Foundation Turkey)minorStrategic or Co-development PartnerSocial responsibility partnerships with autism foundation for inclusive community support.
• TEMA (Turkish Foundation for Combating Soil Erosion)minorStrategic or Co-development PartnerEnvironmental sustainability partnership with TEMA for environmental protection activities.
• TURMEPA (Marine Environment Protection Association)minorStrategic or Co-development PartnerPartnership for marine environment protection and sustainable water resources.
• Türk Eğitim Vakfı (Turkish Education Foundation)minorStrategic or Co-development PartnerEducation support partnership providing scholarships for higher education.
• Hacettepe University Technology Development ZonecoreStrategic or Co-development PartnerUniversity-industry collaboration hosting İLKO ARGEM R&D Center since 2009. Located in Hacettepe University campus providing access to academic expertise and research infrastructure.
• Teknopark İstanbulcoreStrategic or Co-development PartnerTechnology park hosting İLKO ARGEM Biotechnology Center since 2015. Provides ecosystem for biotech startups and R&D companies.

Scale indicators6 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Krka: Slovenian generic pharmaceutical manufacturer with broad Rx portfolio and strong presence in CEE and Balkan markets. Closely comparable in business model, geography expansion pattern into the Balkans, and product portfolio breadth.
• Ali Raif İlaç: Turkish pharmaceutical manufacturer with branded generics across cardiovascular, CNS, and other therapeutic areas. Comparable mid-tier domestic Rx manufacturer with similar therapeutic breadth.
• Abdi İbrahim: Turkey's largest domestic pharmaceutical manufacturer offering branded generics across multiple therapeutic areas. Highly comparable vertically integrated R&D-to-commercial model serving the same Turkish Rx and OTC channels.
• Eczacıbaşı İlaç (EIP): Turkish pharma division of Eczacıbaşı Group operating in Rx, OTC, and consumer health. Comparable diversified Turkish pharma business model serving doctors, pharmacies, and consumers.
• Mustafa Nevzat İlaç: Turkish pharmaceutical manufacturer (now part of Acino) producing branded generics with strong domestic presence. Comparable in size, therapeutic breadth, and Turkish-market positioning.
• Nobel İlaç: Turkish pharmaceutical company focused on branded generics and consumer health products with strong domestic distribution. Comparable portfolio breadth across Rx and OTC and similar reliance on Turkey's reimbursement system.
• Bilim İlaç: Turkish manufacturer of generic pharmaceuticals with broad therapeutic coverage and in-house R&D. Comparable mid-sized domestic competitor with multi-therapy Rx portfolio and consumer health offerings.

Broad incumbents

• Sandoz: Global leader in generics and biosimilars with extensive footprint in Turkey. Relevant benchmark for İLKOGEN's biosimilar ambitions and a competitor in oncology and immunology categories ILKO is targeting.
• Teva Pharmaceutical Industries: Global generic and specialty pharmaceutical leader with broad portfolio including biosimilars. Relevant competitive benchmark for branded generics and a potential partner or competitor in biosimilar categories.

Emerging players

• Alvotech: Pure-play biosimilar developer focused on immunology and oncology with integrated R&D and manufacturing. Comparable to İLKOGEN's biosimilar pipeline strategy and emerging commercial trajectory in regulated markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks1 record

Key highlights7 records

Customer concentration

• Xx.com/ilkoilac
• Facebookfacebook.com/ilkoilac
• LinkedInlinkedin.com/company/ilkoilac

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ILKO Pharmaceuticals